In addition to EV-DNA detection for the diagnosis of pancreas-associated pathologies, the clinical utility of EV-DNA and cfDNA KRAS MAFs in patients with localized and metastatic pancreatic ductal adenocarcinoma was determined, and the results were compared [132]. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.